CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
SentryX is developing a novel drug delivery system called Bupi-Ring that administers bupivacaine, a local anesthetic, directly to surgical sites for over 72 hours. This technology aims to reduce reliance on opioids for pain management after surgery, promoting faster recovery and shorter hospital stays.
There is a troubling lack of effective pain treatments after major surgery.
Especially after musculoskeletal procedures, patients experience debilitating pain now treated with opioids.
Opioids provide insufficient pain relief, have many toxic side-effects, and are highly addictive.
Pain and opioid-related side-effects impede early mobilisation and recovery and are the primary reasons for extended hospital stays.SentryX is developing revolutionary drug delivery technology to extend the effects of…
SENTRYX BV
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.